Genetic heterogeneity profiling for HER2 positive single circulating tumor cell (CTC) in metastatic breast cancer (MBC) by application of DEPArray™ System and single cell DNA sequencing for HER2 positive single circulating tumor cell (CTC) in metastatic breast cancer (MBC) by application DEPArray™ system and single cell DNA sequencing

被引：0
|
作者：
Zhang, Qiang [1 ]
Gerratana, Lorenzo [2 ]
Pivarski, Kara L. [1 ]
Wang, Xinkun [1 ]
Ji, Zhe [1 ]
Stroup, Emily [1 ]
Vagia, Elena Vagia [1 ]
Davis, Andrew Adam Davis A. Adam [1 ]
Shah, Ami [1 ]
Kerby, Katy L. [1 ]
Flaum, Lisa Flaum [1 ]
Wehbe, Firas [1 ]
Zhang, Youbin [1 ]
Qiang, Wenan [1 ]
Behdad, Amir [1 ]
Gradishar, William [1 ]
Platanias, Leonidas [1 ]
Cristofanilli, Massimo [1 ]
机构：
[1] Northwestern Univ Evanston, Chicago, IL USA
[2] Univ Udine, Udine, Italy
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-3120
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3120
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Specific gene alterations of HER2 positive single circulating tumor cell (CTC) compared to autologous leukocytes in metastatic breast cancer (MBC)
    Zhang, Qiang
    Gerratana, Lorenzo
    Ji, Zhe
    Wang, Xinkun
    D'Amico, Paolo
    Singhal, Seema
    Zhang, Youbin
    Davis, Andrew A.
    Shah, Ami N.
    Gradishar, William
    CANCER RESEARCH, 2023, 83 (07)
  • [2] A novel application of DEPArray™ NxT System to isolate circulating tumor cell (CTC)-clusters from patients with metastatic breast cancer (MBC)
    Zhang, Qiang
    Gerratana, Lorenzo
    Shah, Ami N.
    Davis, Andrew A.
    Flaum, Lisa
    Zhang, Youbin
    Behdad, Amir
    Wehbe, Firas
    Gradishar, William
    Platanias, Leonidas
    Cristofanilli, Massimo
    CANCER RESEARCH, 2019, 79 (13)
  • [3] EFFICACY OF LAPATINIB (L) IN METASTATIC BREAST CANCER (MBC) PATIENTS (PTS) WITH HER2 NEGATIVE (-) PRIMARY TUMORS (PT) AND HER2 POSITIVE (+) CIRCULATING TUMOR CELLS (CTC)
    Pestrin, M.
    Bessi, S.
    Minisini, A. M.
    Masci, G.
    Cascinu, S.
    Ravaioli, A.
    Di Marsico, R.
    Tondini, C.
    Buyse, M.
    Di Leo, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 41 - 41
  • [4] Circulating tumor DNA (ctDNA) sequencing for HER2 mutation (HER2mut) screening and response monitoring to neratinib in metastatic breast cancer (MBC)
    Ma, Cynthia
    Bose, Ron
    Gao, Feng
    Freedman, Rachel
    Telli, Melinda
    Kimmick, Gretchen
    Winer, Eric
    Naughton, Michael
    Goetz, Matthew
    Russell, Christy
    Tripathy, Debu
    Cobleigh, Melody
    Forero, Andres
    Pluard, Timothy
    Anders, Carey
    Thomas, Shana
    Anderson, Jill
    Bumb, Caroline
    Banks, Kimberly
    Lanman, Richard
    Bryce, Richard
    Lalani, Alshad
    Pfeifer, John
    Hays, Daniel
    Pegram, Mark
    Blackwell, Kimberly
    Bedard, Philippe
    Al-Kateb, Hussam
    Ellis, Matthew
    CANCER RESEARCH, 2017, 77
  • [5] Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her2 positive metastatic breast cancer (mBC)
    Martines, C.
    Lavenia, G.
    Salice, P.
    Latteri, F.
    Commendatore, O.
    Sambataro, D.
    Burrafato, G.
    Mattina, M.
    Amadio, P.
    Bordonaro, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] Comparison of circulating tumor cell (CTC) derived DNA and circulating cell-free DNA (cfDNA) from simultaneous blood sampling of patients with metastatic breast cancer (MBC)
    Liu, Minetta C.
    Giridhar, Karthik V.
    Ferre, Roberto A. Leon
    Carroll, Jamie L.
    Goetz, Matthew P.
    Haddad, Tufia C.
    Smith, Deanne R.
    Yadav, Siddhartha
    Kapoor, Vidushi
    Liu, Guoying
    George, Tad
    Ericson, Nolan
    Ramirez, Arturo B.
    Kaldjian, Eric
    Haselkorn, Keegan E.
    CANCER RESEARCH, 2020, 80 (16)
  • [7] Single Cell RNA Sequencing Workflow for Circulating Tumor Cells in Metastatic Breast Cancer Research
    Abramova, Anna
    Franken, Andre
    Rivandi, Mahdi
    Yang, Liwen
    Honisch, Ellen
    Niederacher, Dieter
    Fehm, Tanja
    Neubauer, Hans
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 262 - 262
  • [8] Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer
    Aurilio, Gaetano
    Sandri, Maria Teresa
    Pruneri, Giancarlo
    Zorzino, Laura
    Botteri, Edoardo
    Munzone, Elisabetta
    Adamoli, Laura
    Facchi, Giuseppina
    Cullura, Daniela
    Verri, Elena
    Rocca, Maria Cossu
    Zurrida, Stefano
    Iacovelli, Roberto
    Nole, Franco
    FUTURE ONCOLOGY, 2016, 12 (17) : 2001 - 2008
  • [9] Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer
    Ma, Cynthia X.
    Bose, Ron
    Gao, Feng
    Freedman, Rachel A.
    Telli, Melinda L.
    Kimmick, Gretchen
    Winer, Eric
    Naughton, Michael
    Goetz, Matthew P.
    Russell, Christy
    Tripathy, Debu
    Cobleigh, Melody
    Forero, Andres
    Pluard, Timothy J.
    Anders, Carey
    Niravath, Polly Ann
    Thomas, Shana
    Anderson, Jill
    Bumb, Caroline
    Banks, Kimberly C.
    Lanman, Richard B.
    Bryce, Richard
    Lalani, Alshad S.
    Pfeifer, John
    Hayes, Daniel F.
    Pegram, Mark
    Blackwell, Kimberly
    Bedard, Philippe L.
    Al-Kateb, Hussam
    Ellis, Matthew J. C.
    CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5687 - 5695
  • [10] Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients
    Banys-Paluchowski, Malgorzata
    Witzel, Isabell
    Riethdorf, Sabine
    Rack, Brigitte
    Janni, Wolfgang
    Fasching, Peter Andreas
    Solomayer, Erich-Franz
    Aktas, Bahriye
    Kasimir-Bauer, Sabine
    Pantel, Klaus
    Fehm, Tanja
    Mueller, Volkmar
    ANTICANCER RESEARCH, 2017, 37 (06) : 3117 - 3128
12345